T he Precision Medicine Initiative
1 promises a new healthcare era. A proposed 1 millionÀperson cohort could create a deeper understanding of disease causation. Improvements in quality of sequencing, reduction in price, and advances in "omic" fields and biotechnology promise a new era, variably labeled personalized or precision medicine. Although genomics is one driver of precision health care, other factors may be as important (e.g., health information technology).
Both excitement and skepticism met the announcement.
2 Public health experts are concerned about the disproportionate emphasis on genes, drugs, and disease, while neglecting strategies to address social determinants of health. A prime concern for public health is promoting health, preventing disease, and reducing health disparities by focusing on modifiable morbidity and mortality. In 2014, CDC estimated the annual number of potentially preventable deaths from the top five causes in the U.S.
3 Data suggest that at least one third of deaths are potentially preventable by reducing prevalence of known risk factors (e.g., smoking, poor diet, and inadequate physical activity).
Could the same technologies that propel precision medicine usher in a parallel era of "precision public health" beyond treatment of sick individuals? If precision medicine is about providing the right treatment to the right patient at the right time, precision public health can be simply viewed as providing the right intervention to the right population at the right time. More-accurate methods for measuring disease, pathogens, exposures, behaviors, and susceptibility could allow better assessment of population health and development of policies and targeted programs for preventing disease. The initial drive toward precision public health is occurring, but much more work lies ahead to develop a robust evidentiary foundation for use. The following are examples of priority areas.
Role of Multidisciplinary Public Health Sciences
Though precision medicine focuses on individualized care, its success truly requires a population-based approach. To learn what interventions work for whom, data on each individual need to be compared with data from large, diverse numbers of people to identify population subgroups likely to respond differently to interventions. In addition, collecting information from large numbers of people is far more informative when diverse people are included from the underlying population. Using data from convenience samples alone (i.e., collected without regard to important factors such as race/ethnicity, age, and sex) can lead to selection bias and unreliable prediction models. To guard against selection bias, a strong epidemiologic cohort design is needed to ensure diversity and representation of the underlying population, as well as unbiased assessment of genetic and environmental factors. 4 Additionally, successful implementation requires multiple disciplines (e.g., research on patient-centered outcomes, comparative effectiveness, communication). A multidisciplinary science agenda goes beyond traditional bench to bedside. For precision medicine to succeed, a population perspective is needed. Education of patients, families, physicians, payers, and the public health community will be needed. This is where strong public healthÀhealthcare partnerships are essential in assessing the needs of individuals and communities, developing effective policies and guidelines, ensuring that all people have access to the intended benefits, and tracking costeffectiveness outcomes in the real world.
Shifting the Focus From Treatment to Prevention
A compelling case can be made for more attention to prevention and early detection. Although personalized treatments can help save the lives of sick people, prevention applies to all. "Precision prevention" may be
